Discontinued — last reported Q2 '22
Current Liabilities
Income Taxes Payable
Pfizer Income Taxes Payable increased by 5.6% to $3.59B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 41.2%, from $6.11B to $3.59B. Over 5 years (FY 2020 to FY 2025), Income Taxes Payable shows a downward trend with a -20.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ3 2017
Last reportedQ2 2022
How to read this metric
An increase often reflects higher taxable income, while a decrease may indicate tax payments made or lower taxable earnings.
Detailed definition
This represents the current portion of income tax obligations owed to various government taxing authorities based on tax...
Peer comparison
Common across all profitable corporations, varying based on effective tax rates and jurisdictional tax laws.
Metric ID:
income_taxes_payableHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $11.26B | $11.34B | $11.33B | $11.57B | $10.99B | $9.70B | $9.81B | $9.86B | $8.05B | $8.10B | $8.53B | $8.60B | $6.53B | $5.91B | $6.11B | $5.72B | $3.31B | $3.40B | $3.59B |
| QoQ Change | — | +0.7% | -0.0% | +2.1% | -5.0% | -11.7% | +1.1% | +0.5% | -18.3% | +0.6% | +5.4% | +0.8% | -24.1% | -9.6% | +3.5% | -6.3% | -42.1% | +2.7% | +5.6% |
| YoY Change | — | — | — | — | -2.4% | -14.4% | -13.4% | -14.8% | -26.7% | -16.5% | -13.0% | -12.7% | -18.9% | -27.1% | -28.4% | -33.5% | -49.3% | -42.4% | -41.2% |
Range$3.31B – $11.57B
CAGR-22.4%
Avg YoY Growth-23.7%
Median YoY Growth-18.9%
Current Streak2 quarters growth
Income Taxes Payable at Other Companies
Frequently Asked Questions
- What is Pfizer's income taxes payable?
- Pfizer (PFE) reported income taxes payable of $3.59B in Q4 2025.
- How has Pfizer's income taxes payable changed year-over-year?
- Pfizer's income taxes payable decreased by 41.2% year-over-year, from $6.11B to $3.59B.
- What is the long-term trend for Pfizer's income taxes payable?
- Over 5 years (2020 to 2025), Pfizer's income taxes payable has grown at a -20.8% compound annual growth rate (CAGR), from $11.56B to $3.59B.
- What does income taxes payable mean?
- The amount of income tax the company owes to government authorities for the current period.